FDSVX
Price
$74.87
Change
+$0.75 (+1.01%)
Updated
Jul 31 closing price
Net Assets
6.33B
RGAHX
Price
$83.75
Change
+$0.96 (+1.16%)
Updated
Jul 31 closing price
Net Assets
356.86B
Interact to see
Advertisement

FDSVX vs RGAHX

FDSVX vs RGAHX Comparison Chart in %
View a ticker or compare two or three
VS
FDSVX vs. RGAHX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDSVX is a Buy and RGAHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 357B vs. FDSVX (6.33B). RGAHX pays higher dividends than FDSVX: RGAHX (0.41) vs FDSVX (0.16). FDSVX was incepted earlier than RGAHX: FDSVX (28 years) vs RGAHX (11 years). FDSVX (0.62) is less costly to investors than RGAHX (0.44). FDSVX is a more actively managed with annual turnover of: 60.00 vs. RGAHX (32.00). FDSVX has a lower initial minimum investment than RGAHX: FDSVX (0) vs RGAHX (250). FDSVX annual gain was more profitable for investors over the last year : 10.52 vs. RGAHX (1.64). FDSVX return over 5 years is better than : 25.94 vs. RGAHX (13.85).
FDSVXRGAHXFDSVX / RGAHX
Total Expense Ratio0.620.44141%
Annual Report Gross Expense Ratio0.620.44141%
Fund Existence28 years11 years-
Gain YTD7.2485.692127%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.33B357B2%
Annual Yield % from dividends0.160.4138%
Returns for 1 year10.521.64643%
Returns for 3 years45.1036.31124%
Returns for 5 years25.9413.85187%
Returns for 10 years194.3099.57195%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLSI4.54-0.02
-0.44%
TriSalus Life Sciences
UBS52.74-0.65
-1.22%
UBS Group AG
LNTH99.64-1.36
-1.35%
Lantheus Holdings
AVBP29.82-0.84
-2.74%
ArriVent BioPharma
DFNS27.68-57.30
-67.43%
T3 Defense Inc